The Food and Drug Administration
(FDA), Center for Tobacco Products (CTP), is proposing to collect
information from tobacco manufacturers and/or their agents via a
letter to become better informed about the impact of the use and
public health effects of tobacco products. This proposed ICR will
collect information regarding the effects of smokeless tobacco
product pH on the public health under the Federal Food, Drug, and
Cosmetic Act (FD&C Act), as amended by the Family Smoking
Prevention and Tobacco Control Act (the Tobacco Control Act). The
information collected will include information that industry is
required to provide under the FD&C Act, as well as voluntary
information requests beyond the inquiries described in the FD&C
Act. FDA will use the information collected to assess the effects
of product pH of smokeless tobacco products on consumers and the
public health.
PL:
Pub.L. 111 - 31 31 Name of Law: Family Smoking Prevention and
Tobacco Control Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.